New Enterprise Associates 14 is a Venture Capital Fund in Maryland with $5.88 bn assets under management, with a minimum investment of $50.00 k. It has 219 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$5.88 bn
Address
New Enterprise Associates 14
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD 21093
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD 21093
Phone
410-842-4000
Ownership
Fund structure | AUM | Fund type |
---|---|---|
New Enterprise Associates | $27.00 bn | |
Nea 15 Opportunity Fund, L.P. | $828.28 mm | Venture Capital Fund |
Nea 18 Venture Growth Equity, L.P. | $574.95 mm | Venture Capital Fund |
Nea BH SPV II, L.P. | $10.39 mm | Venture Capital Fund |
Nea BH SPV, L.P. | $27.11 mm | Venture Capital Fund |
Nea Presidents Fund, L.P. | $192.53 k | Venture Capital Fund |
New Enterprise Associates 10, Limited Partnership | $213.62 mm | Venture Capital Fund |
New Enterprise Associates 11, Limited Partnership | $175.40 mm | Venture Capital Fund |
New Enterprise Associates 12, Limited Partnership | $327.72 mm | Venture Capital Fund |
Presidents Fund II, L.P. | ||
New Enterprise Associates 13, L.P. | $914.47 mm | Venture Capital Fund |
Presidents Fund III, L.P. | ||
New Enterprise Associates 14, L.P. | $5.88 bn | Venture Capital Fund |
Nea 14 Manager Fund, L.P. | ||
New Enterprise Associates 15, L.P. | $3.82 bn | Venture Capital Fund |
New Enterprise Associates 16, L.P. | $4.24 bn | Venture Capital Fund |
New Enterprise Associates 17, L.P. | $3.06 bn | Venture Capital Fund |
New Enterprise Associates 18, L.P. | $435.37 mm | Venture Capital Fund |
New Enterprise Associates 8A, Limited Partnership | $14.05 mm | Venture Capital Fund |
New Enterprise Associates 9, Limited Partnership | $16.94 mm | Venture Capital Fund |
New Enterprise Associates VIII, Limited Partnership | $24.61 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13D/A
CHAMPIONS ONCOLOGY, INC.
6 May 24
144
Tuya Inc./ADR
19 Apr 24
SC 13D/A
Adaptimmune Therapeutics PLC
2 Apr 24
SC 13D/A
SYNLOGIC, INC.
13 Oct 23
3
PATRICK J KERINS
6 Oct 23
SC 13D/A
Adaptimmune Therapeutics PLC
30 Mar 23
SC 13G/A
Tuya Inc.
3 Feb 23
SC 13D/A
Oyster Point Pharma, Inc.
9 Jan 23
4
PATRICK J KERINS
4 Jan 23
SC 13D/A
Oyster Point Pharma, Inc.
21 Nov 22
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 23 | New Enterprise Associates 14 | Common Stock | Dispose U | No | No | 0 | 5,925,287 | 0.00 | 0 |